Business Wire Feed
RenalEdge GPO Welcomes Trace Medical as a New Vendor Partner
Participants Gain Access to Flexible Dialysis Machine Rental SolutionsWHITMORE LAKE, Mich.--(BUSINESS WIRE)--RenalEdge GPO is pleased to announce a new vendor partnership with Trace Medical, a national provider of dialysis machine rentals, home medical equipment solutions, more...
OhioHealth Taps Qventus to Automate Care Operations Across the Enterprise
Following proven success with Qventus' Inpatient Capacity Solution, OhioHealth expands its partnership to transform the perioperative journey for patientsSAN FRANCISCO--(BUSINESS WIRE)--Qventus, the leader in automated care operations software for health systems, today announced that OhioHealth more...
OpenEvidence Launches New Education Platform Offering Continuing Education (CE) and Maintenance of Certification (MOC) Credit
MIAMI--(BUSINESS WIRE)--#CME--OpenEvidence, the leading AI-powered medical search and decision support platform, has launched a new education platform offering accredited, interprofessional continuing education (CE) and Maintenance of Certification (MOC) credits for NPI-verified physicians, nurse practitioners, and more...
BrainChip AKD1500 Now Available in Compact M.2 Form Factor, Enabling Fanless Edge AI in Industrial and Commercial Designs
Lower-cost, lower-power edge AI accelerator gives designers a plug-and-play path to upgrade legacy systems to AkidaLAGUNA HILLS, Calif.--(BUSINESS WIRE)--BrainChip Holdings Ltd. (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), a global leader in ultra-low power, fully digital, more...
Golden Valley Memorial Healthcare Selected as Hub Anchor for Missouri Rural Health Transformation Program
CLINTON, Mo.--(BUSINESS WIRE)--Golden Valley Memorial Healthcare (GVMH) has been selected by the Missouri Department of Social Services (DSS) to serve as a Hub Anchor organization for Missouri's Rural Health Transformation Program (RHTP) through its Transformation more...
Grindr for Equality Commits to Connecting 10M to HIV Prevention by 2028
New report finds PrEP awareness is high but access is low, as global HIV funding shrinks Grindr steps upRIO DE JANEIRO--(BUSINESS WIRE)--Today at the 2026 International AIDS Conference, Grindr for Equality committed to connecting ten more...
Segal Survey Projects Health Plan Cost Trend to Reach 15-Year Historic Highs Driven by GLP-1s, Inflation, AI, and Surprise Billing Arbitration
NEW YORK--(BUSINESS WIRE)--Segal, a leading benefits and HR consulting firm, today issued the 2027 Segal Health Plan Cost Trend Survey. The 30th annual survey report reveals that health plan cost trends for employer-sponsored benefits are more...
Massive Bio and GELL Announce Strategic Partnership to Advance Research, Medical Education, and Artificial Intelligence Across Latin America and the United States
Collaboration combines GELL's extensive Latin American investigator network with Massive Bio's AI-driven clinical trial matching platform to expand physician education, scientific exchange, and patient access to precision oncologyBOCA RATON, Fla.--(BUSINESS WIRE)--Massive Bio, a global leader more...
Feinstein Institutes Unveils World’s First Comprehensive Vagus Nerve Map, Substantiating Decades of Leadership in Bioelectronic Medicine
This pioneering dataset was funded through a $6.7 million NIH multi-year grant and offers unprecedented insights into the vagus nerve’s intricate anatomyMANHASSET, N.Y.--(BUSINESS WIRE)--Northwell Health’s Feinstein Institutes for Medical Research has announced the groundbreaking release more...
Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the second quarter of 2026 on Monday, August 10, 2026, before trading begins on the New York Stock Exchange. The more...
Huonslab Secures Patent for ADC Subcutaneous Formulation Incorporating ‘HyDIFFUZE™’ Platform
Demonstrates competitiveness of hyaluronidase-based ADC SC conversion platformConfirms stability of high-concentration ADC SC formulations and improved drug dispersionPANGYO, South Korea--(BUSINESS WIRE)--#ADC--Huonslab, the R&D subsidiary of Huons Group (KOSDAQ:084110), announced that it has secured a patent more...
Dopl Technologies Raises $6.3M in Seed Funding to Advance Proprietary Telerobotic Ultrasound Toward FDA Clearance
The oversubscribed round led by SpringTide Ventures raised total funding for Dopl to more than $8M and will advance product development, clinical evaluation, and initial pilot deploymentsBOTHELL, Wash.--(BUSINESS WIRE)--Dopl Technologies, a Bothell, Washington-based medical technology more...
Vasomune Therapeutics to Present on Pegevongitide Therapeutic Capability at the 2026 NATO NSPA CBRN
Dr. Brian Jahns will present a therapeutics capability update of Pegevongitide (AV-001), Vasomune's dual-use drug candidate targeting vascular leak, an underlying pathology across casualty careTORONTO--(BUSINESS WIRE)--#ARDS--Vasomune Therapeutics, Inc. ("Vasomune"), a clinical-stage biopharmaceutical company developing therapies more...
Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference
LOS ANGELES--(BUSINESS WIRE)--$NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Chief Executive Officer, Rob Fried, and more...
Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026
Key facts: Thermo Fisher’s specialty diagnostics portfolio addresses high-impact clinical needs across multiple myeloma monitoring with the EXENT® Solution, community oncology testing, critical care, allergy and autoimmune diagnostics, including connective tissue disease testing with the more...
AHF Backs Africa Union’s Debt Reform Push
KAMPALA, Uganda--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) welcomed the African Union’s focus on debt sustainability at this week’s Specialized Technical Committees session in Abidjan, Côte d’Ivoire, while urging African leaders to continue pushing for structural reforms more...
Biointron Launches RushData, an Integrated Platform for AI-Driven Antibody Discovery with 1-Day CHO Expression
1-day CHO expression for data generation in days, not weeks, for standardized, structured datasets ready for AI/ML-driven design Custom workflows for targets and modalities, with 3,000+ molecules per batch processed in parallel Identify liabilities early more...
Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2026 financial results before market opening on Tuesday, August 4, 2026. The Company will host a conference call and webcast at more...
EndoQuest Robotics Announces Completion of Enrollment in the PARADIGM Trial
PARADIGM Trial enrollment concludes following the successful completion of fifty robotic endoscopic submucosal dissection procedures by six different investigators Preliminary trial results presented at the 2026 Society of Robotic Surgery Annual MeetingHOUSTON--(BUSINESS WIRE)--EndoQuest Robotics, Inc., more...
Kao USA Updates Voluntary Recall of Some Lots of Oribe Serene Scalp Densifying Shampoo in the U.S.
One additional lot of Oribe Serene Scalp Densifying Shampoo (8.5 oz) identified in the U.S.CINCINNATI--(BUSINESS WIRE)--Kao USA Inc. (“Kao USA”) today has updated its previously announced voluntary recall of select lots of its Oribe Serene more...
Northwell Scientist Reveals Breakthrough Results in Eye Cancer Drug
Published in Nature, new clinical trial data for uveal melanoma therapy sparks hope for future patient solutionsMANHASSET, N.Y.--(BUSINESS WIRE)--Patients with metastatic uveal melanoma (UM), an aggressive eye cancer, often face a survival rate of less more...
Apex Infusion Partners with SkyKnight Capital
SAN FRANCISCO--(BUSINESS WIRE)--Apex Infusion ("Apex" or the "Company"), a leading omnichannel infusion services provider, has entered into a definitive agreement to partner with SkyKnight Capital, L.P. ("SkyKnight"), a private equity firm with a track record more...
New Analysis of Phase 3 Pooled Data for Organon’s VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults1
The presentation at the 2026 Society for Pediatric Dermatology (SPD) Annual Meeting marked the first time pooled Phase 3 data from the ADORING 1 and 2 trials on Validated Investigator Global Assessment for Atopic Dermatitis more...
Enhertu® Plus Pertuzumab Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with HER2 Positive Metastatic Breast Cancer
Recommendation based on DESTINY-Breast09 phase 3 trial results that showed Enhertu plus pertuzumab reduced the risk of disease progression or death by 44% versus THP with a median progression-free survival exceeding three years If approved, more...
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development
Multi-faceted strategy aims to enable rapid, broad and sustainable access to alimatravir (MK-8527), if approved, in low- and middle-income countries Voluntary licensing agreements cover 129 countries in regions which account for the substantial majority of more...